361 related articles for article (PubMed ID: 34372698)
1. Multifactorial Role of Mitochondria in Echinocandin Tolerance Revealed by Transcriptome Analysis of Drug-Tolerant Cells.
Garcia-Rubio R; Jimenez-Ortigosa C; DeGregorio L; Quinteros C; Shor E; Perlin DS
mBio; 2021 Aug; 12(4):e0195921. PubMed ID: 34372698
[TBL] [Abstract][Full Text] [Related]
2. Macrophage internalization creates a multidrug-tolerant fungal persister reservoir and facilitates the emergence of drug resistance.
Arastehfar A; Daneshnia F; Cabrera N; Penalva-Lopez S; Sarathy J; Zimmerman M; Shor E; Perlin DS
Nat Commun; 2023 Mar; 14(1):1183. PubMed ID: 36864040
[TBL] [Abstract][Full Text] [Related]
3. Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata.
Singh-Babak SD; Babak T; Diezmann S; Hill JA; Xie JL; Chen YL; Poutanen SM; Rennie RP; Heitman J; Cowen LE
PLoS Pathog; 2012; 8(5):e1002718. PubMed ID: 22615574
[TBL] [Abstract][Full Text] [Related]
4. Critical Assessment of Cell Wall Integrity Factors Contributing to
Garcia-Rubio R; Hernandez RY; Clear A; Healey KR; Shor E; Perlin DS
Front Microbiol; 2021; 12():702779. PubMed ID: 34305871
[TBL] [Abstract][Full Text] [Related]
5. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.
Alexander BD; Johnson MD; Pfeiffer CD; Jiménez-Ortigosa C; Catania J; Booker R; Castanheira M; Messer SA; Perlin DS; Pfaller MA
Clin Infect Dis; 2013 Jun; 56(12):1724-32. PubMed ID: 23487382
[TBL] [Abstract][Full Text] [Related]
6. Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint.
Garcia-Effron G; Lee S; Park S; Cleary JD; Perlin DS
Antimicrob Agents Chemother; 2009 Sep; 53(9):3690-9. PubMed ID: 19546367
[TBL] [Abstract][Full Text] [Related]
7. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
8. The Gastrointestinal Tract Is a Major Source of Echinocandin Drug Resistance in a Murine Model of Candida glabrata Colonization and Systemic Dissemination.
Healey KR; Nagasaki Y; Zimmerman M; Kordalewska M; Park S; Zhao Y; Perlin DS
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971865
[No Abstract] [Full Text] [Related]
9. Clumping Morphology Influences Virulence Uncoupled from Echinocandin Resistance in Candida glabrata.
Hu C; Fong G; Wurster S; Kontoyiannis DP; Beyda ND
Microbiol Spectr; 2022 Feb; 10(1):e0183721. PubMed ID: 35107318
[TBL] [Abstract][Full Text] [Related]
10.
Jiménez-Ortigosa C; Perez WB; Angulo D; Borroto-Esoda K; Perlin DS
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630180
[TBL] [Abstract][Full Text] [Related]
11. Resistance to echinocandin antifungal agents in the United Kingdom in clinical isolates of Candida glabrata: Fifteen years of interpretation and assessment.
Fraser M; Borman AM; Thorn R; Lawrance LM
Med Mycol; 2020 Feb; 58(2):219-226. PubMed ID: 31111912
[TBL] [Abstract][Full Text] [Related]
12. Comparative Genomics of Serial
Barber AE; Weber M; Kaerger K; Linde J; Gölz H; Duerschmied D; Markert A; Guthke R; Walther G; Kurzai O
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30478162
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting Fungal Echinocandin Resistance by Small-Molecule Disruption of Geranylgeranyltransferase Type I Activity.
Sun Q; Xiong K; Yuan Y; Yu J; Yang L; Shen C; Su C; Lu Y
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31791942
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and Molecular Evaluation of Echinocandin Susceptibility of Candida glabrata, Candida bracarensis, and Candida nivariensis Strains Isolated during 30 Years in Argentina.
Morales-López S; Dudiuk C; Vivot W; Szusz W; Córdoba SB; Garcia-Effron G
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461313
[TBL] [Abstract][Full Text] [Related]
15. Stress-Induced Changes in the Lipid Microenvironment of β-(1,3)-d-Glucan Synthase Cause Clinically Important Echinocandin Resistance in Aspergillus fumigatus.
Satish S; Jiménez-Ortigosa C; Zhao Y; Lee MH; Dolgov E; Krüger T; Park S; Denning DW; Kniemeyer O; Brakhage AA; Perlin DS
mBio; 2019 Jun; 10(3):. PubMed ID: 31164462
[No Abstract] [Full Text] [Related]
16. Systematic phenotyping of a large-scale Candida glabrata deletion collection reveals novel antifungal tolerance genes.
Schwarzmüller T; Ma B; Hiller E; Istel F; Tscherner M; Brunke S; Ames L; Firon A; Green B; Cabral V; Marcet-Houben M; Jacobsen ID; Quintin J; Seider K; Frohner I; Glaser W; Jungwirth H; Bachellier-Bassi S; Chauvel M; Zeidler U; Ferrandon D; Gabaldón T; Hube B; d'Enfert C; Rupp S; Cormack B; Haynes K; Kuchler K
PLoS Pathog; 2014 Jun; 10(6):e1004211. PubMed ID: 24945925
[TBL] [Abstract][Full Text] [Related]
17. Absence of Azole or Echinocandin Resistance in Candida glabrata Isolates in India despite Background Prevalence of Strains with Defects in the DNA Mismatch Repair Pathway.
Singh A; Healey KR; Yadav P; Upadhyaya G; Sachdeva N; Sarma S; Kumar A; Tarai B; Perlin DS; Chowdhary A
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610199
[No Abstract] [Full Text] [Related]
18. Echinocandin Resistance in Candida.
Perlin DS
Clin Infect Dis; 2015 Dec; 61 Suppl 6(Suppl 6):S612-7. PubMed ID: 26567278
[TBL] [Abstract][Full Text] [Related]
19. Echinocandin-Induced Microevolution of Candida parapsilosis Influences Virulence and Abiotic Stress Tolerance.
Papp C; Kocsis K; Tóth R; Bodai L; Willis JR; Ksiezopolska E; Lozoya-Pérez NE; Vágvölgyi C; Mora Montes H; Gabaldón T; Nosanchuk JD; Gácser A
mSphere; 2018 Nov; 3(6):. PubMed ID: 30429225
[No Abstract] [Full Text] [Related]
20. Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management.
Perlin DS
Drugs; 2014 Sep; 74(14):1573-85. PubMed ID: 25255923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]